Adagio Medical Holdings (ADGM) Gross Profit (2023 - 2025)
Adagio Medical Holdings (ADGM) reported Gross Profit of -$58000.0 for Q4 2025, down 87.1% on a QoQ basis from -$31000.0 in Q3 2025.
Adagio Medical Holdings (ADGM) has 3 years of Gross Profit data on file, last reported at -$58000.0 in Q4 2025.
- Quarterly Gross Profit changed N/A year-over-year to -$58000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$624000.0 (changed N/A YoY) and the FY2025 annual result came in at -$684000.0, up 58.99% from the prior year.
- Gross Profit declined to -$58000.0 in Q4 2025 per ADGM's latest filing, from -$31000.0 in the prior quarter.
- Across five years, Gross Profit topped out at -$31000.0 in Q3 2025 and bottomed at -$516000.0 in Q1 2024.
- The 3-year median for Gross Profit is -$254500.0 (2023), against an average of -$254500.0.
- The widest annual swing landed in 2024, when Gross Profit slumped 33.02%; it then soared 89.01% in 2025.
- Tracing ADGM's Gross Profit over 3 years: stood at -$256000.0 in 2023, then retreated by 10.16% to -$282000.0 in 2024, then jumped by 79.43% to -$58000.0 in 2025.
- Per Business Quant, the three latest ADGM Gross Profit figures stand at -$58000.0 (Q4 2025), -$31000.0 (Q3 2025), and -$253000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Adagio Medical Holdings | 16.86 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58,000.00 |
| Dec 31, 2025 | -58,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Sep 30, 2024 | -282,000.00 |
| Sep 30, 2024 | -282,000.00 |
| Jun 30, 2024 | -428,000.00 |
| Jun 30, 2024 | -428,000.00 |
| Mar 31, 2024 | -516,000.00 |
| Mar 31, 2024 | -516,000.00 |
| Dec 31, 2023 | -256,000.00 |
| Dec 31, 2023 | -256,000.00 |
| Sep 30, 2023 | -212,000.00 |
| Sep 30, 2023 | -212,000.00 |